Literature DB >> 17960764

Differential distribution of PDE4B splice variant mRNAs in rat brain and the effects of systemic administration of LPS in their expression.

Elisabet Reyes-Irisarri1, Silvia Pérez-Torres, Xavier Miró, Emili Martínez, Pere Puigdomènech, José M Palacios, Guadalupe Mengod.   

Abstract

Phosphodiesterases (PDE) control intracellular cyclic adenosine monophosphate (cAMP) levels, which appear to play an important role in the regulation of inflammation. PDE4B is especially important in this process. Using in situ hybridization histochemistry we first mapped the expression sites of the four PDE4B splicing forms in rat brain. Using the systemic administration of the bacterial endotoxin lipopolysaccharide (LPS) as an inflammation model in rats, we found an increase in PDEB2 mRNA expression in choroid plexus. The differential expression of PDE4B spliced forms and the differential regulation of PDE4B2 in an inflammatory model further supports an involvement of this splicing variant in the inflammatory response. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17960764     DOI: 10.1002/syn.20459

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  13 in total

Review 1.  Phosphodiesterase inhibitors as therapeutics for traumatic brain injury.

Authors:  David J Titus; Anthony A Oliva; Nicole M Wilson; Coleen M Atkins
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 2.  PDE4 as a target for cognition enhancement.

Authors:  Wito Richter; Frank S Menniti; Han-Ting Zhang; Marco Conti
Journal:  Expert Opin Ther Targets       Date:  2013-07-25       Impact factor: 6.902

3.  Phosphodiesterase 4b expression plays a major role in alcohol-induced neuro-inflammation.

Authors:  Diana V Avila; Scott A Myers; JingWen Zhang; Giorgi Kharebava; Craig J McClain; Hee-Yong Kim; Scott R Whittemore; Leila Gobejishvili; Shirish Barve
Journal:  Neuropharmacology       Date:  2017-08-12       Impact factor: 5.250

4.  Ferulic acid prevents LPS-induced up-regulation of PDE4B and stimulates the cAMP/CREB signaling pathway in PC12 cells.

Authors:  Hao Huang; Qian Hong; Hong-Ling Tan; Cheng-Rong Xiao; Yue Gao
Journal:  Acta Pharmacol Sin       Date:  2016-09-26       Impact factor: 6.150

5.  RACK1 and β-arrestin2 attenuate dimerization of PDE4 cAMP phosphodiesterase PDE4D5.

Authors:  Graeme B Bolger
Journal:  Cell Signal       Date:  2015-08-06       Impact factor: 4.315

6.  Chronic Cognitive Dysfunction after Traumatic Brain Injury Is Improved with a Phosphodiesterase 4B Inhibitor.

Authors:  David J Titus; Nicole M Wilson; Julie E Freund; Melissa M Carballosa; Kevin E Sikah; Concepcion Furones; W Dalton Dietrich; Mark E Gurney; Coleen M Atkins
Journal:  J Neurosci       Date:  2016-07-06       Impact factor: 6.167

7.  Specific Inhibition of Phosphodiesterase-4B Results in Anxiolysis and Facilitates Memory Acquisition.

Authors:  Alexander McGirr; Tatiana V Lipina; Ho-Suk Mun; John Georgiou; Ahmed H Al-Amri; Enoch Ng; Dongxu Zhai; Christina Elliott; Ryan T Cameron; Jonathan G L Mullins; Fang Liu; George S Baillie; Steven J Clapcote; John C Roder
Journal:  Neuropsychopharmacology       Date:  2015-08-14       Impact factor: 7.853

8.  Therapeutic benefits of phosphodiesterase 4B inhibition after traumatic brain injury.

Authors:  Nicole M Wilson; Mark E Gurney; W Dalton Dietrich; Coleen M Atkins
Journal:  PLoS One       Date:  2017-05-19       Impact factor: 3.240

Review 9.  Selective phosphodiesterase inhibitors: a promising target for cognition enhancement.

Authors:  Olga A H Reneerkens; Kris Rutten; Harry W M Steinbusch; Arjan Blokland; Jos Prickaerts
Journal:  Psychopharmacology (Berl)       Date:  2008-08-16       Impact factor: 4.530

10.  Altered phosphorylation, electrophysiology, and behavior on attenuation of PDE4B action in hippocampus.

Authors:  Susan L Campbell; Thomas van Groen; Inga Kadish; Lisa High Mitchell Smoot; Graeme B Bolger
Journal:  BMC Neurosci       Date:  2017-12-02       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.